Greenberg; Philip D.

Patent Applications and Registrations

Patent applications and USPTO patent grants for Greenberg; Philip D..The latest application filed is for "high avidity wt1 t cell receptors and uses thereof".

Company Profile

5.9.14

Greenberg; Philip D. - Mercer Island WA
Greenberg; Philip D. - Seattle WA

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Binding proteins specific for RAS neoantigens and uses thereof Grant 11,382,954 - Perret , et al. July 12, 2	2022-07-12
High Avidity Wt1 T Cell Receptors And Uses Thereof App 20220160764 - SCHMITT; Thomas M. ; et al.	2022-05-26
Binding Proteins Specific For Ras Neoantigens And Uses Thereof App 20220160832 - PERRET; Rachel ; et al.	2022-05-26
T Cell Receptors Specific For Mesothelin And Their Use In Immunotherapy App 20220009992 - SCHMITT; Thomas M. ; et al.	2022-01-13
Immunomodulatory Fusion Proteins And Uses Thereof App 20210403532 - Oda; Shannon K. ; et al.	2021-12-30
Binding Proteins Specific For Ras Neoantigens And Uses Thereof App 20210379150 - PERRET; Rachel ; et al.	2021-12-09
High affinity T cell receptors and uses thereof Grant 11,026,969 - Schmitt , et al. June 8, 2	2021-06-08
Cyclin A1 Specific T Cell Receptors And Uses Thereof App 20200405762 - PERRET; Rachel ; et al.	2020-12-31
Enhanced affinity T cell receptors and methods for making the same Grant 10,875,904 - Schmitt , et al. December 29, 2	2020-12-29
T cell immunotherapy specific for WT-1 Grant 10,538,572 - Schmitt , et al. Ja	2020-01-21
Immunomodulatory Fusion Proteins And Uses Thereof App 20200009190 - Oda; Shannon K. ; et al.	2020-01-09
Engineered high-affinity human t cell receptors Grant 10,344,075 - Smith , et al. July 9, 2	2019-07-09
Immunomodulatory Il2r Fusion Proteins And Uses Thereof App 20190127435 - SCHMITT; Thomas M. ; et al.	2019-05-02
High Affinity T Cell Receptors And Uses Thereof App 20180369280 - SCHMITT; Thomas M. ; et al.	2018-12-27
Immunomodulatory Fusion Proteins And Uses Thereof App 20180044404 - Oda; Shannon K. ; et al.	2018-02-15
Enhanced Affinity T Cell Receptors And Methods For Making The Same App 20170362298 - SCHMITT; Thomas M. ; et al.	2017-12-21
Enhanced affinity T cell receptors and methods for making the same Grant 9,751,928 - Schmitt , et al. September 5, 2	2017-09-05
Engineered High-affinity Human T Cell Receptors App 20160280756 - Smith; Sheena N. ; et al.	2016-09-29
T Cell Immunotherapy Specific For Wt-1 App 20160083449 - Schmitt; Thomas M. ; et al.	2016-03-24
Enhanced Affinity T Cell Receptors And Methods For Making The Same App 20150118208 - Schmitt; Thomas M. ; et al.	2015-04-30
High efficiency transduction of T lymphocytes using rapid expansion methods ("REM") Grant 6,040,177 - Riddell , et al. March 21, 2	2000-03-21
Rapid expansion method ("REM") for in vitro propagation of T lymphocytes Grant 5,827,642 - Riddell , et al. October 27, 1	1998-10-27
Chimeric cytokine receptors in lymphocytes Grant 5,747,292 - Greenberg , et al. May 5, 1	1998-05-05

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.